Overview
With its estimated growth to nearly $1 billion by 2024, New Jersey’s cannabis industry is increasingly front and center in the minds of savvy entrepreneurs and investors alike. However, no industry is exempt from risk, and those servicing, operating or investing in the medical and recreational cannabis sectors are faced with a particularly complex regulatory environment.
Drawing from the depth of our experienced attorneys across a myriad of disciplines, our Cannabis Law Team is uniquely qualified to help the sector’s stakeholders navigate regulatory complexity, understand their rights and capitalize on this promising field.
Our team has been fortunate to represent several dynamic applicant groups on the path to medicinal licensure pursuant to the New Jersey Department of Health’s 2018 and 2019 Requests for Applications. Leveraging this experience, and now that recreational cannabis has been legalized in New Jersey, the Group is already working towards positioning aspiring industry participants for successful entry into this lucrative space as licensing opportunities in the recreational marketplace begin to take real shape.
To this end, the CSG Cannabis Law Team helps address a full range of issues in support of the medical and recreational cannabis sectors, including:
- Licensing
- Compliance and corporate governance
- Government and regulatory affairs
- Trademark and copyright
- Litigation
- Banking and finance
- Taxation
- Employment
- Raising and deploying capital
- Real estate and land use
- Environmental concerns
- Corporate and commercial transactions
Disclaimer: Using, possessing, distributing and/or selling marijuana is illegal under federal law, regardless of any state law. Businesses and individuals should be aware that compliance with state law does not assure compliance with federal law. No legal advice we give is intended to provide any guidance or assistance in violating federal law.
